Healthcare · Pharmaceuticals

Orchid Pharma Ltd (ORCHPHARMA)

₹965.80

Mkt cap
₹5,672 Cr
P/E ratio
314.00
P/B
3.80
Div yield
0.00%
ROE
1.35%
ROCE
1.73%
EPS (TTM)
₹3.08
Book value
₹254
52W range
482–1,101
Sector
Healthcare

Price history

Previous close

Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. [1]

NSE ORCHPHARMABSE 524372
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−12.31% from high
₹966
₹482+100.19% from low₹1,101
Current
₹965.80
Prev close
₹946.45
Day
+2.04%
Price performance
1D
+2.04%
1W
+1.89%
1M
−10.50%
3M
+13.50%
6M
+79.32%
1Y
+31.34%
YTD
+21.54%

Financials

Revenue, profit & margin
P/E ratio
314.0×
ORCHPHARMA is 795% above the sector median of 35.1×
ORCHPHARMA314.0×
Sector median35.1×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales182.92198.76220.59217.10244.41222.70217.34237.48263.19193.52207.27368.33304.17
Expenses160.78175.46185.21188.19211.92192.36190.97209.49268.84194.99205.71338.17290.17
Operating Profit22.1423.3035.3828.9132.4930.3426.3727.99-5.65-1.471.5630.1614.00
OPM %12.10%11.72%16.04%13.32%13.29%13.62%12.13%11.79%-2.15%-0.76%0.75%8.19%4.60%
Other Income1.898.367.6213.367.577.528.493.9011.5710.77-1.507.551.83
Interest5.553.803.543.473.503.333.803.922.283.733.181.962.23
Depreciation7.717.849.278.428.448.638.618.8710.538.909.0310.9010.95
Profit before tax10.7720.0230.1930.3828.1225.9022.4519.10-6.89-3.33-12.1524.852.65
Tax %0.00%0.00%0.00%-10.27%-0.53%0.00%0.00%-0.21%0.00%0.00%0.00%0.00%2.64%
Net Profit9.4019.8029.4332.9629.3527.2420.7822.29-5.69-5.72-12.6125.843.22
EPS in Rs1.853.905.806.505.795.374.104.39-1.12-1.13-2.495.090.63
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −4.52% · closed higher next day 0 of last 2
 Q4FY26Q1FY27
Broadcast14 Aug '2614 Aug '26
Earnings day−4.52%−4.52%
+1 day−7.31%−7.31%
+5 days−0.72%−0.72%
+15 days−9.49%−9.49%
+30 days
FilingPDFXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
69.84%Promoter
Promoters69.84%
FIIs0.80%0.07
DIIs20.75%0.51
Public8.62%0.42
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
SUNPHARMA₹1,895.0035.994,54,6740.84%2,901+5.95%15,300+10.46%20.53%
DIVISLAB₹9,315.0083.002,47,2840.32%902+65.50%3,080+27.80%21.97%
TORNTPHARM₹4,914.0083.771,86,9130.77%566+5.79%4,921+54.85%15.19%
ZYDUSLIFE₹1,156.9023.701,15,4010.09%990−35.09%8,017+21.96%21.14%
CIPLA₹1,395.0031.491,12,6960.93%786−39.19%7,119+2.33%15.49%
LAURUSLABS₹1,876.7092.741,01,4000.11%362+125.49%2,026+29.10%17.76%
LUPIN₹2,105.0016.1796,2540.86%1,417+16.08%8,277+32.04%29.93%
ORCHPHARMA₹947.10314.055,6720.00%3+156.59%304+15.57%1.73%
Median: 159 Co.₹423.0035.072,2820.08%13+29.60%162+18.62%15.04%

Filings